APA

Burel-Vandenbos F., Ngo-Mai M., Dadone B., Di Mauro I., Gimet S., Saada-Bouzid E., Bourg V., Almairac F., Fontaine D., Virolle T. & Pedeutour F. (20180411). MET immunolabelling is a useful predictive tool for MET gene amplification in glioblastoma. : Neuropathology and applied neurobiology.

Chicago

Burel-Vandenbos F, Ngo-Mai M, Dadone B, Di Mauro I, Gimet S, Saada-Bouzid E, Bourg V, Almairac F, Fontaine D, Virolle T and Pedeutour F. 20180411. MET immunolabelling is a useful predictive tool for MET gene amplification in glioblastoma. : Neuropathology and applied neurobiology.

Harvard

Burel-Vandenbos F., Ngo-Mai M., Dadone B., Di Mauro I., Gimet S., Saada-Bouzid E., Bourg V., Almairac F., Fontaine D., Virolle T. and Pedeutour F. (20180411). MET immunolabelling is a useful predictive tool for MET gene amplification in glioblastoma. : Neuropathology and applied neurobiology.

MLA

Burel-Vandenbos F, Ngo-Mai M, Dadone B, Di Mauro I, Gimet S, Saada-Bouzid E, Bourg V, Almairac F, Fontaine D, Virolle T and Pedeutour F. MET immunolabelling is a useful predictive tool for MET gene amplification in glioblastoma. : Neuropathology and applied neurobiology. 20180411.